Latest Articles & Resources FEATURED CordenPharma CEO on Scaling GLP-1 Production and Competing in Complex Modalities Read More » CordenPharma CEO on Scaling GLP-1 Production and Competing in Complex Modalities Read More » LATEST NEWS + INTERVIEWS mAbxience Launches AI Project with HP to Optimise Biologic Manufacturing Benuvia Operations Forms Integrated CRO–CDMO Platform with CCRP for Schedule I–V Therapeutics Thermo Fisher Scientific Expands Bioprocessing Network Across Asia Robust Analytics for Novel Modalities: Industry Leaders Share Strategies Polyrizon Completes Manufacturing Upscaling Milestone for PL-14 Nasal Spray Platform BioNexus Gene Lab Secures $500M Financing Facility to Support CDMO and Diagnostics Expansion AGC Biologics Partners with ATUM to Integrate Leap-In Transposase Platform into Cell Line Development WuXi Biologics Signs MoU with Qatar Free Zones Authority to Establish First Middle East CRDMO Centre Rentschler Biopharma Announces Strategic Collaboration with Coriolis Pharma for Integrated Development Services Cellipont Bioservices Completes Cleanroom Expansion with New 50-litre Bioreactor eXmoor Pharma Forms Strategic Collaboration with UCL TRO to Accelerate CGT Development US–UK Deal Sets Zero Tariffs, Raises UK Drug Value Thresholds What BioPlan’s 22-Year Data Reveals About the Future of Biopharmaceutical Outsourcing Mycenax Forms Joint Venture Alfenax Biologics to Build Japanese Biosimilars CDMO NorthX Biologics Completes GMP Certification for Mendus’ Vididencel Manufacturing Samsung Biologics Secures Land for New Campus to Expand CDMO Modalities Grindeks Group Introduces New CDMO and Out-Licensing Services Piramal Pharma Solutions Achieves Full Compliance with Global Nitrosamine Requirements medac CDMO Supports UroGen Pharma in Advancing UGN-103 Toward NDA Submission eXmoor Pharma Forms Strategic Collaboration with Royal Free London’s CVIC How Piramal Pharma Built a $1 Billion CDMO by Solving Client Problems, Not Selling Services PODCAST INTERVIEWS CordenPharma CEO on Scaling GLP-1 Production and Competing in Complex Modalities What BioPlan’s 22-Year Data Reveals About the Future of Biopharmaceutical Outsourcing How Piramal Pharma Built a $1 Billion CDMO by Solving Client Problems, Not Selling Services
AGC Biologics Partners with ATUM to Integrate Leap-In Transposase Platform into Cell Line Development
Rentschler Biopharma Announces Strategic Collaboration with Coriolis Pharma for Integrated Development Services